Valuation : Cipla Limited

Market Cap 1,150B 12.11B 10.45B 9.83B 8.95B 16.84B 16.93B 116B 45.22B 585B 45.48B 44.49B 1,939B P/E 2027 *
27.7x
P/E 2028 * 22.3x
Enterprise Value 1,043B 11B 9.48B 8.92B 8.13B 15.28B 15.37B 105B 41.05B 531B 41.28B 40.39B 1,760B EV / Sales 2027 *
3.37x
EV / Sales 2028 * 2.93x
Free-Float
65.42%
Yield 2027 *
0.91%
Yield 2028 * 1.04%
1 day+0.98%
1 week-1.04%
Current month+0.98%
1 month-3.41%
3 months+1.57%
6 months+5.55%
Current year-5.84%
1 week 1,401.1
Extreme 1401.1
1,426.1
1 month 1,401.1
Extreme 1401.1
1,488.1
Current year 1,165.7
Extreme 1165.7
1,539.7
1 year 1,165.7
Extreme 1165.7
1,673
3 years 1,132
Extreme 1132
1,702.05
5 years 850
Extreme 850
1,702.05
10 years 355.3
Extreme 355.3
1,702.05
Manager TitleAgeSince
Chief Executive Officer - 2026-03-31
President - 2026-05-17
Director of Finance/CFO - 2026-07-23
Director TitleAgeSince
Chairman 90 1972-07-20
Director/Board Member 72 2014-07-24
Director/Board Member 71 2021-06-29
Date Insider Type Main position Quantity % Market Cap. Importance
8/22/24 Sell 2,000 0.0002%
8/14/24 Sell 3,000 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
+0.98%-1.04%-10.47%+13.15% 11.96B
-2.81%+0.99%+20.98%+73.53% 50.05B
+1.14%+1.47%+59.54%+123.40% 40.29B
+0.56%+5.80%+19.04%+86.59% 12.17B
+0.19%+0.97%+29.35%+148.80% 9.25B
-0.15%-1.87%+25.21%+46.24% 7.62B
-0.39%+3.33%+28.41%+222.15% 7.36B
+1.43%+1.70%+50.00%-9.99% 7.21B
-0.13%+0.79%-36.70%+15.26% 5.26B
-2.70%-2.10%+41.46%+102.89% 4.73B
Average -0.19%+1.01%+22.68%+82.20% 15.59B
Weighted average by Cap. -0.52%+1.71%+29.45%+88.01%

Financials

2027 *2028 *
Net sales 310B 3.27B 2.82B 2.65B 2.41B 4.54B 4.56B 31.32B 12.19B 158B 12.26B 11.99B 523B 347B 3.66B 3.16B 2.97B 2.71B 5.09B 5.11B 35.1B 13.66B 177B 13.74B 13.44B 586B
Net income 41.35B 436M 376M 354M 322M 606M 609M 4.18B 1.63B 21.04B 1.64B 1.6B 69.75B 51.42B 542M 467M 440M 400M 753M 757M 5.2B 2.02B 26.15B 2.03B 1.99B 86.72B
Net Debt -106B -1.12B -964M -907M -826M -1.55B -1.56B -10.72B -4.17B -53.96B -4.2B -4.11B -179B -131B -1.38B -1.19B -1.12B -1.02B -1.93B -1.94B -13.29B -5.17B -66.86B -5.2B -5.09B -222B
Logo Cipla Limited
Cipla specializes in development, manufacturing and marketing of pharmaceutical products. The group provides prescription products and OTC medicines for the treatment of cardiovascular, ophthalmic and dermatological diseases, respiratory troubles, cancers, allergies, infections etc. Besides, Cipla develops and sells veterinary products. Net sales by source of income break down between sale of products (96.9%) and services (3.1%). Net sales are distributed geographically as follows: India (39.4%), the United States (18.5%), South Africa (17%) and other (25.1%).
Employees
31,369
Date Price Change Volume
26-09-01 1,423.00 +0.98% 880,100
26-08-31 ₹1,409.20 -1.00% 977,929
26-08-28 ₹1,423.50 +0.25% 377,976
26-08-27 ₹1,420.00 +1.23% 533,212
26-08-26 ₹1,402.70 -1.36% 915,493
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
36
Last Close Price
1,423.00INR
Average target price
1,509.08INR
Spread / Average Target
+6.05%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CIPLA Stock